rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Garrett Lustig

Director

Company insider

Files Form 4 as: Director, Organogenesis Holdings.

In numbers

Trades disclosed
3
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
19 Feb 2025
Last trade
18 Feb 2026
Last filed
20 Feb 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ORGO Organogenesis HoldingsDirector · Biotechnology · last 18 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
19 Feb 2025filed 21 Feb 2025ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—49,575 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Brian GrowChief Commercial Officer · Chief Commercial Officer at Organogenesis Holdings, filing Form 4 there in the last year
Michael Joseph DriscollDirector · Director at Organogenesis Holdings, filing Form 4 there in the last year
Arthur S. LeibowitzDirector · Director at Organogenesis Holdings, filing Form 4 there in the last year
Patrick BilboChief Operating Officer · Chief Operating Officer at Organogenesis Holdings, filing Form 4 there in the last year
Antonio S. MontecalvoVice President, Health Policy · Vice President, Health Policy at Organogenesis Holdings, filing Form 4 there in the last year